Qilu Pharmaceutical Co., Ltd.: all 211 studies

Page 2 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant TumorsNot yet recruitingNCT06394713Phase 1/2
• A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast CancerRecruitingNCT06383767Phase 3
• A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy AdultsRecruitingNCT06371534Phase 1
• A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal AdenocarcinomaRecruitingNCT06261359Phase 2
• A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy AdultsRecruitingNCT06173011Phase 1
• A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in ChildrenRecruitingNCT06151587Phase 3
• A Study of QL1706H in Patients With Advanced Solid TumorsNot yet recruitingNCT06047431Phase 1
• A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid TumorsNot yet recruitingNCT06041035Phase 1/2
• A Study of QLF3108 in Participants With Advanced Solid TumorRecruitingNCT06019013Phase 1
• A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT05976568Phase 2/3
• Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT05973149Phase 1
• Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 DiabetesNot yet recruitingNCT05950516Phase 3
• a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergencyNot yet recruitingNCT05922436Phase 3
• A Study of QLS32015 in Patients With Recurrent or Refractory Multiple MyelomaRecruitingNCT05920876Phase 1
• Phase I Study of QLS1103 in Subjects With Advanced Solid TumorsRecruitingNCT05884801Phase 1
• A Phase I Study of QLP2117 in Subjects With Advanced Solid TumorsRecruitingNCT05830045Phase 1
• A Phase I Study of QLS12004 in Patients With Advanced Solid TumorsNot yet recruitingNCT05829616Phase 1
• A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor PatientsRecruitingNCT05823285Phase 1
• A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast CancerNot yet recruitingNCT05802342Phase 2/3
• QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRCRecruitingNCT05799820Phase 2
• To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR MutationRecruitingNCT05555212Phase 1
• Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.RecruitingNCT05488821Phase 1
• A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.RecruitingNCT05487391Phase 3
• Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid TumorsRecruitingNCT05461287Phase 1
• QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical CancerRecruitingNCT05446883Phase 3
• A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant TumorsRecruitingNCT05150405Phase 1
• QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and SafetyRecruitingNCT04233151Phase 3
• Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFRNot yet recruitingNCT03381430Not applicable
• A Phase 3 Clinical Study of QL2106 InjectionActive, not recruitingNCT07511647Phase 3
• A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2106 vs Tremfye® in Healthy SubjectsCompletedNCT07479576Phase 1
• Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese AdultsCompletedNCT07331545Phase 1
• Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT07162883Phase 3
• To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.CompletedNCT07081256Phase 3
• Lifitegrast Eye Drops in Healthy Subjects：Phase I StudyCompletedNCT07040826Phase 1
• Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingCompletedNCT06932107Phase 3
• Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female VolunteersActive, not recruitingNCT06864793Phase 1
• Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate CancerCompletedNCT06837896Phase 3
• Study on the Efficacy and Safety of QLM1016 in SchizophreniaActive, not recruitingNCT06799559Phase 3
• Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory StudyCompletedNCT06742216Phase 3
• A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®CompletedNCT06614907Phase 1
• Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy VolunteersCompletedNCT06254235Phase 1
• A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy VolunteersCompletedNCT06232902Phase 1
• A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisCompletedNCT06058000Phase 2
• Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult SubjectsCompletedNCT05932888Phase 1
• Bioequivalence Study of Two Olaparib Tablets in Patients With CancersCompletedNCT05860530Not applicable
• Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced ThrombocytopeniaCompletedNCT05851027Phase 2/3
• Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial CarcinomaStatus unknownNCT05823246Phase 2
• A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.Status unknownNCT05822713Phase 3
• A Study of Olanzapine in Patients With Acute AgitationStatus unknownNCT05803642Phase 3
• Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT05801107Phase 2
• A Phase I Study of QL1604 for Advanced Solid TumorsStatus unknownNCT05801094Phase 1
• A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19Status unknownNCT05758519Phase 3
• Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male VolunteersCompletedNCT05716126Phase 1
• A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeStatus unknownNCT05703204Phase 1
• A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung CancerActive, not recruitingNCT05690945Phase 3
• A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19Status unknownNCT05689203Phase 2
• A Phase I Study of QL1604 in Subjects With Advanced Solid TumorsStatus unknownNCT05649761Phase 1
• A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated PainStatus unknownNCT05648669Phase 3
• A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast CancerCompletedNCT05629949Phase 3
• Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune ThrombocytopeniaCompletedNCT05621330Phase 3
• A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT05603039Phase 1/2
• A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal CarcinomaActive, not recruitingNCT05576272Phase 2/3
• A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical CancerStatus unknownNCT05557565Phase 2
• Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced ThrombocytopeniaCompletedNCT05554913Phase 2/3
• Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy VolunteersCompletedNCT05531994Not applicable
• Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy VolunteersCompletedNCT05528198Not applicable
• A Study of QLS1128 and in Combination With Ritonavir in Healthy ParticipantsStatus unknownNCT05458076Phase 1
• A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)CompletedNCT05345236Phase 3
• A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung CancerActive, not recruitingNCT05329025Phase 2
• Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung CancerCompletedNCT05309629Phase 2
• A Study of QLS31905 in Patients With Advanced Solid TumorsStatus unknownNCT05278832Phase 1
• A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC)Status unknownNCT05262413Phase 1/2
• A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple MyelomaStatus unknownNCT05236621Phase 3
• Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical CancerStatus unknownNCT05179317Phase 2
• A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid TumorsStatus unknownNCT05171790Phase 1
• Efficacy and Safety of QL1012 in Women for Assisted Reproductive TreatmentCompletedNCT05149924Phase 3
• QLF32004 Injection for the Treatment of Patients With Advanced Malignant TumorsStatus unknownNCT05108779Phase 1
• Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract InfectionsStatus unknownNCT05060419Phase 2
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)CompletedNCT05058118Phase 1
• Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)CompletedNCT05058105Phase 1
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)CompletedNCT05055687Phase 1
• CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT05052567Phase 1/2
• PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell MalignanciesStatus unknownNCT05003141Phase 1
• A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic MalignanciesStatus unknownNCT04954456Phase 1
• QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical CancerTerminatedNCT04864782Phase 2/3
• Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder CancerStatus unknownNCT04859751Phase 3
• A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy SubjectsStatus unknownNCT04651036Phase 1
• A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung CancerStatus unknownNCT04641754Phase 2
• Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) PatientsActive, not recruitingNCT04632758Phase 3
• Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.CompletedNCT04629846Phase 3
• To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid TumorsStatus unknownNCT04550949Phase 3
• A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.Status unknownNCT04435652Phase 2/3
• QL1604 Monotherapy for dMMR or MSI-H Advanced Solid TumorsStatus unknownNCT04326829Phase 2
• A Study of QL1706 in Subjects With Advanced Malignant TumorStatus unknownNCT04296994Phase 1
• Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.Status unknownNCT04234594Phase 1
• Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy AdultsStatus unknownNCT04213105Phase 1
• An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis bStatus unknownNCT04157699Phase 2
• An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
• Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture RiskStatus unknownNCT04128163Phase 3
• A Study of PSB205 in Subjects With Advanced Solid TumorsStatus unknownNCT03986606Phase 1

← Qilu Pharmaceutical Co., Ltd. overview and focus areas